Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-07-19

FDA Approved: CLARINEX-D 12 HOUR — Supplemental Application (Organon LLC)

View source ↗

Summary

The FDA approved a supplemental application for CLARINEX-D 12 HOUR, a combination product of desloratadine and pseudoephedrine sulfate from Organon LLC. Deslora…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLARINEX-D 12 HOUR (DESLORATADINE AND PSEUDOEPHEDRINE SULFATE)

Snippet

SUPPL AP for CLARINEX-D 12 HOUR (DESLORATADINE AND PSEUDOEPHEDRINE SULFATE)